Benzinga | Nov 29, 2021 08:22AM EST

Morgan Stanley Maintains Equal-Weight on Merck & Co, Lowers Price Target to $82

Morgan Stanley analyst Matthew Harrison maintains Merck & Co (NYSE:MRK) with a Equal-Weight and lowers the price target from $88 to $82.